An example might be COVID-19-associated hyperferritinemia associated with increased IL-6, in which ferritin and IL-6 may serve as biomarkers of ferroptosis: ferroptosis inhibitors may have a therapeutic role in that setting [14]. This evidence concerns the gene IL6 and isolated hyperferritinemia.